Literature DB >> 8228297

Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Rwanda, 1984-1990.

J Bogaerts1, P Lepage, H Taelman, D Rouvroy, J Batungwanayo, P Kestelyn, D G Hitimana, P Van de Perre, J Vandepitte, L Verbist.   

Abstract

A total of 383 clinical isolates of Streptococcus pneumoniae, obtained from an equal number of patients in Kigali, Rwanda, was tested for resistance to penicillin G with a 1 microgram oxacillin disc. Of these isolates, 99 (25.8%) showed reduced zones of inhibition. By means of an agar dilution method, 21% all isolates were confirmed as relatively resistant (MIC > or = 0.12- < or = 1.0 mg/l) strains of Streptococcus pneumoniae (RRSP). A high degree of resistance to penicillin G (MIC > or = 2 mg/l) was not observed. Resistance to chloramphenicol (MIC > or = 8 mg/l) was found in 31% RRSP and in 6% penicillin susceptible strains (PSSP). Doxycycline resistance was common in both RRSP and PSSP strains. All isolates remained fully susceptible to erythromycin. Children more often harboured a strain giving a reduced inhibition zone than did adults (74/230 versus 25/153; P = 0.0005). A total of 32 serotypes or serogroups were identified, seven of them relating to 64.8% all isolates typed. Of all the isolates 84% belonged to a serotype represented in the 23-valent vaccine or to a cross-reacting serotype. Serotype 25, not included in the vaccine, accounted for 10.7% typed isolates from adults but only for 2.0% typed isolates from children. Results of susceptibility testing and clinical experience suggest that penicillin G, ampicillin and chloramphenicol should not be used alone as empirical treatment for pneumococcal meningitis in patients in Rwanda.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8228297     DOI: 10.1016/0163-4453(93)94728-t

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  5 in total

1.  Two-year surveillance of antibiotic resistance in Streptococcus pneumoniae in four African cities.

Authors:  M Benbachir; S Benredjeb; C S Boye; M Dosso; H Belabbes; A Kamoun; O Kaire; N Elmdaghri
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Persistence of two invasive Streptococcus pneumoniae clones of serotypes 1 and 5 in comparison to that of multiple clones of serotypes 6B and 23F among children in southern Israel.

Authors:  N Porat; R Trefler; R Dagan
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Five-Year Antimicrobial Susceptibility Trends Among Bacterial Isolates from a Tertiary Health-Care Facility in Kigali, Rwanda.

Authors:  Makeda Carroll; Ashok Rangaiahagari; Emmanuel Musabeyezu; Donald Singer; Onyema Ogbuagu
Journal:  Am J Trop Med Hyg       Date:  2016-10-31       Impact factor: 2.345

Review 4.  Resistant Pneumococcus: a worldwide problem.

Authors:  G E Schutze; S L Kaplan; R F Jacobs
Journal:  Infection       Date:  1994 Jul-Aug       Impact factor: 3.553

5.  Dissemination of a chloramphenicol- and tetracycline-resistant but penicillin-susceptible invasive clone of serotype 5 Streptococcus pneumoniae in Colombia.

Authors:  M Tamayo; R Sá-Leão; I Santos Sanches; E Castañeda; H de Lencastre
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.